{"pmid":32475168,"title":"COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.","text":["COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.","J Diabetes Sci Technol","Ceriello, Antonio","Schnell, Oliver","32475168"],"journal":"J Diabetes Sci Technol","authors":["Ceriello, Antonio","Schnell, Oliver"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475168","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1932296820930025","keywords":["covid-19","sars -cov-2","continuous glucose monitoring","diabetes","glucose variability","intensive care unit","telemedicine"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1668437834945527808,"score":9.490897,"similar":[{"pmid":32429701,"title":"Personal Experience With COVID-19 and Diabetes in the South of France: Technology Facilitates the Management of Diabetes in Disruptive Times.","text":["Personal Experience With COVID-19 and Diabetes in the South of France: Technology Facilitates the Management of Diabetes in Disruptive Times.","We report our experience with COVID-19 epidemic in patients with type 1 diabetes using diabetes technology in the South of France. Use of insulin pumps and continuous glucose monitoring appeared as an effective way to prevent the risk of acute metabolic complications related to the changes of daily life associated with requested confinement . Care by telemedicine was facilitated in these patients who used diabetes technology while structured education delivered during training and support from home care services were helpful to master the disruptive conditions.","J Diabetes Sci Technol","Renard, Eric","32429701"],"abstract":["We report our experience with COVID-19 epidemic in patients with type 1 diabetes using diabetes technology in the South of France. Use of insulin pumps and continuous glucose monitoring appeared as an effective way to prevent the risk of acute metabolic complications related to the changes of daily life associated with requested confinement . Care by telemedicine was facilitated in these patients who used diabetes technology while structured education delivered during training and support from home care services were helpful to master the disruptive conditions."],"journal":"J Diabetes Sci Technol","authors":["Renard, Eric"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32429701","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/1932296820929370","keywords":["covid-19","continuous glucose monitoring","diabetes technology","insulin pump","telemedicine"],"locations":["France"],"countries":["France"],"countries_codes":["FRA|France"],"e_drugs":["Glucose"],"topics":["Prevention"],"weight":1,"_version_":1667342288382066688,"score":100.51523},{"pmid":32443962,"title":"How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future.","text":["How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future.","J Diabetes Sci Technol","Castle, Jessica R","Rocha, Lolis","Ahmann, Andrew","32443962"],"journal":"J Diabetes Sci Technol","authors":["Castle, Jessica R","Rocha, Lolis","Ahmann, Andrew"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32443962","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/1932296820929368","keywords":["covid-19","continuous glucose monitoring","novel coronavirus","type 1 diabetes","type 2 diabetes"],"topics":["Prevention"],"weight":1,"_version_":1667600475791294464,"score":71.517296},{"pmid":32460543,"title":"Personal Experiences With COVID-19 and Diabetes Technology: All for Technology Yet Not Technology for All.","text":["Personal Experiences With COVID-19 and Diabetes Technology: All for Technology Yet Not Technology for All.","J Diabetes Sci Technol","Monaghan, Maureen","Marks, Brynn","32460543"],"journal":"J Diabetes Sci Technol","authors":["Monaghan, Maureen","Marks, Brynn"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32460543","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1177/1932296820930005","keywords":["covid-19","continuous glucose monitoring","diabetes technology","pediatric","telehealth"],"weight":0,"_version_":1668079521352384513,"score":71.10164},{"pmid":32416526,"title":"Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic.","text":["Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic.","Diabetes Metab Syndr","Ghosh, Amerta","Dutta, Koel","Tyagi, Kanika","Gupta, Ritesh","Misra, Anoop","32416526"],"journal":"Diabetes Metab Syndr","authors":["Ghosh, Amerta","Dutta, Koel","Tyagi, Kanika","Gupta, Ritesh","Misra, Anoop"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416526","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.dsx.2020.05.010","keywords":["covid-19","diabetes","telemedicine"],"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666994545970118656,"score":68.40248},{"pmid":32275971,"pmcid":"PMC7138381","title":"COVID-19 in patients with diabetes: risk factors that increase morbidity.","text":["COVID-19 in patients with diabetes: risk factors that increase morbidity.","Metabolism","Klonoff, David C","Umpierrez, Guillermo E","32275971"],"journal":"Metabolism","authors":["Klonoff, David C","Umpierrez, Guillermo E"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275971","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.metabol.2020.154224","keywords":["covid-19","corticosteroid","diabetes","risk","telemedicine"],"topics":["Treatment"],"weight":1,"_version_":1666138491685175298,"score":67.126785}]}